Dissatisfaction after implantation of extended depth-of-focus intraocular lenses.

IF 2.6 3区医学 Q2 OPHTHALMOLOGY

Journal of cataract and refractive surgery Pub Date : 2025-01-21 DOI:10.1097/j.jcrs.0000000000001615

Joukje C Wanten, Noël J C Bauer, Tos T J M Berendschot, Frank J H M van den Biggelaar, Rudy M M A Nuijts

{"title":"Dissatisfaction after implantation of extended depth-of-focus intraocular lenses.","authors":"Joukje C Wanten, Noël J C Bauer, Tos T J M Berendschot, Frank J H M van den Biggelaar, Rudy M M A Nuijts","doi":"10.1097/j.jcrs.0000000000001615","DOIUrl":null,"url":null,"abstract":"Purpose: To evaluate the symptoms, etiology and treatment of patient dissatisfaction after extended depth-of-focus (EDOF) intraocular lens (IOL) implantation.Setting: University Eye Clinic, Maastricht University Medical Center, the Netherlands.Design: Retrospective case series.Methods: For this study, all medical records of patients who received an EDOF IOL from July 2020 to July 2022 were reviewed. Patients were included if they had reported any dissatisfaction after surgery. The main outcome parameters were reasons for dissatisfaction (subjective complaints) and the presumed etiology of the complaints.Results: Out of 202 patients (354 eyes) who underwent EDOF IOL implantation, 83 eyes (22.8%) of 52 dissatisfied patients were included. Blurred vision was the predominant complaint, reported in 78 eyes (94%). Photic phenomena were reported in 21 eyes (25.3%), with 16 eyes (76.2%) experiencing coexisting blurred vision. The major etiologies for dissatisfaction in this cohort were residual ametropia (51.8%), dry eye disease (26.5%), and posterior capsular opacification (12.0%). Treatments were administered to 85.5% of the eyes, including interventions such as artificial tears, spectacles, or refractive surgery enhancement. A small number of patients (n=12; 5.9%) remained dissatisfied despite intervention.Conclusion: Based on this real-world data study, dissatisfaction following EDOF IOL implantation can be effectively identified and treated in most cases.","PeriodicalId":15214,"journal":{"name":"Journal of cataract and refractive surgery","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cataract and refractive surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/j.jcrs.0000000000001615","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: To evaluate the symptoms, etiology and treatment of patient dissatisfaction after extended depth-of-focus (EDOF) intraocular lens (IOL) implantation.

Setting: University Eye Clinic, Maastricht University Medical Center, the Netherlands.

Design: Retrospective case series.

Methods: For this study, all medical records of patients who received an EDOF IOL from July 2020 to July 2022 were reviewed. Patients were included if they had reported any dissatisfaction after surgery. The main outcome parameters were reasons for dissatisfaction (subjective complaints) and the presumed etiology of the complaints.

Results: Out of 202 patients (354 eyes) who underwent EDOF IOL implantation, 83 eyes (22.8%) of 52 dissatisfied patients were included. Blurred vision was the predominant complaint, reported in 78 eyes (94%). Photic phenomena were reported in 21 eyes (25.3%), with 16 eyes (76.2%) experiencing coexisting blurred vision. The major etiologies for dissatisfaction in this cohort were residual ametropia (51.8%), dry eye disease (26.5%), and posterior capsular opacification (12.0%). Treatments were administered to 85.5% of the eyes, including interventions such as artificial tears, spectacles, or refractive surgery enhancement. A small number of patients (n=12; 5.9%) remained dissatisfied despite intervention.

Conclusion: Based on this real-world data study, dissatisfaction following EDOF IOL implantation can be effectively identified and treated in most cases.

查看原文本刊更多论文

人工晶状体植入术后的不满意。

目的：探讨扩大聚焦深度人工晶状体植入术后患者不满意的症状、病因及治疗方法。地点：荷兰马斯特里赫特大学医学中心大学眼科诊所。设计：回顾性病例系列。方法：本研究回顾了2020年7月至2022年7月接受EDOF人工晶状体的患者的所有病历。如果患者在手术后报告有任何不满，则纳入患者。主要结局参数为不满意的原因（主观投诉）和投诉的推定病因。结果：202例患者（354眼）行EDOF人工晶状体植入术，52例患者中有83眼（22.8%）不满意。视力模糊是主要的主诉，78眼（94%）报告。21眼（25.3%）出现光性现象，16眼（76.2%）同时出现视力模糊。不满意的主要病因是残余屈光不正（51.8%）、干眼症（26.5%）和后囊膜混浊（12.0%）。85.5%的眼睛接受了治疗，包括人工泪液、眼镜或屈光手术增强等干预措施。少数患者(n=12；5.9%)仍不满意。结论：基于本研究，EDOF人工晶状体植入术后的不满意在大多数情况下可以有效识别和治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

$Journal of cataract and refractive surgery$

Journal of cataract and refractive surgery 医学-外科

CiteScore

5.60

自引率

14.30%

发文量

259

审稿时长

8.5 weeks

期刊介绍： The Journal of Cataract & Refractive Surgery (JCRS), a preeminent peer-reviewed monthly ophthalmology publication, is the official journal of the American Society of Cataract and Refractive Surgery (ASCRS) and the European Society of Cataract and Refractive Surgeons (ESCRS). JCRS publishes high quality articles on all aspects of anterior segment surgery. In addition to original clinical studies, the journal features a consultation section, practical techniques, important cases, and reviews as well as basic science articles.